Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3

Front Immunol. 2022 Jun 29:13:900254. doi: 10.3389/fimmu.2022.900254. eCollection 2022.

Abstract

Atherosclerosis is one of the main complications of diabetes mellitus, involving a variety of pathogenic factors. Endothelial dysfunction, inflammation, and oxidative stress are hallmarks of diabetes mellitus and atherosclerosis. Although the ability of diabetes to promote atherosclerosis has been demonstrated, a deeper understanding of the underlying biological mechanisms is critical to identifying new targets. NLRP3 plays an important role in both diabetes and atherosclerosis. While the diversity of its activation modes is one of the underlying causes of complex effects in the progression of diabetes and atherosclerosis, it also provides many new insights for targeted interventions in metabolic diseases.

Keywords: NLRP3; NLRP3 inhibitor; atherosclerosis; diabetes mellitus; dyslipidemia; endothelial dysfunction; hyperglycemia.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atherosclerosis* / pathology
  • Diabetes Mellitus* / etiology
  • Humans
  • Inflammation / complications
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Oxidative Stress

Substances

  • NLR Family, Pyrin Domain-Containing 3 Protein